Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials

Publication | Closed Access

DOI

Citations

References

2012

Year

Carine Bellera, Marina Pulido, Sophie Gourgou, Laurence Collette, A. Doussau, Andrew Kramar, Tienhan Sandrine Dabakuyo‐Yonli, M. Ouali, Anne Aupérin, Thomas Filleron,

European Journal of Cancer

Time-to-event EndpointsClinical Trial DesignOncologyMedicineCancer ManagementClinical EndpointClinical TrialsCancer TrialsOutcomes ResearchPatient-reported OutcomeBiostatisticsCancer Clinical TrialsClinical EndpointsRadiation OncologyCancer ResearchRadiologyHealth Sciences